Latest / The BioHub - by Avetix
Episode 215 - Kathleen Gallagher - CEO at Atrium Therapeutics
We were delighted to be joined by Kathleen Gallagher, CEO of Atrium Therapeutics.
Kathleen has built a fascinating career across the biotech industry, with experience spanning corporate communications, investor relations, clinical development and executive leadership. Before founding Atrium, she spent time at companies including Merrimack Pharmaceuticals and Akcea Therapeutics, before joining Avidity Biosciences, where she ultimately became Chief Program Officer.
At Avidity, Kathleen was closely involved in the company’s evolution and the development of its RNA therapeutics platform…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.